Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
7,506,105
-
Share change
-
+7,506,105
-
Total reported value
-
$219,924,000
-
Price per share
-
$29.31
-
Number of holders
-
38
-
Value change
-
+$219,924,064
-
Number of buys
-
38
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2016
As of 31 Mar 2016,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,506,105 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, Hillhouse Capital Management, Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Boxer Capital, LLC, Temasek Holdings (Private) Ltd, Rock Springs Capital Management LP, INDUS CAPITAL PARTNERS, LLC, QVT Financial LP, and RA CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.